A database of FDA approved therapeutic peptides and proteins
| ID | ThPPID | Name | Peptide Sequence | Length | Functional Classification | Disease | Brand | Company | Physical Appearance | Route of Administartion | Category | Target |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1059 | Th1010 | Interferon alfa-n1 | CDLPQTHSLGSRRTLMLLAQ Full view | 165 | Ib | Infectious /Immunological | Wellferon | GlaxoSmithKline | Solution | Injection | Antiviral Agents, Immunologic factors, Immunosuppressiv agents | Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
| 1187 | Th1024 | Gramicidin D | VGALAVVVWLWLWLWX Full view | 16 | IIa | Infectious | Neosporin | Pfizer | Ointment | External use only | Anti-Bacterial Agents, Anti-infective, Topical, Antibiotic | N.A. |
| 1188 | Th1024 | Gramicidin D | VGALAVVVWLWLWLWX Full view | 16 | IIa | Infectious | Sofradex | Sanofi | Sterile, clear, bright, colourless, aqueous solution | Auricular and Ocular use. | Anti-Bacterial Agents, Anti-infective, Topical, Antibiotic | N.A. |
| 1257 | Th1036 | Aldesleukin | MAPTSSSTKKTQLQLEHLLL Full view | 134 | Ib | Cancer/Infectious | Proleukin | Chiron Corp | Sterile, white to off-white, lyophilized cake | Intravenous administration | Antineoplastic Agents, Anti-HIV agents | Interleukin-2 receptor subunit beta,Interleukin-2 receptor subunit alpha,Cytokine receptor common subunit gamma |
| 1341 | Th1049 | Interferon beta-1a | MSYNLLGFLQRSSNFQCQKL Full view | 166 | Ib | Cancer/Infectious/Immunological | Avonex | Biogen Inc | Lyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector. | Intramuscular Injection | Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
| 1342 | Th1049 | Interferon beta-1a | MSYNLLGFLQRSSNFQCQKL Full view | 166 | Ib | Cancer/Infectious/Immunological | Betaferon | Bayer | Powder and solvent that are made upto make solution. | Subcutaneous Injection | Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
| 1343 | Th1049 | Interferon beta-1a | MSYNLLGFLQRSSNFQCQKL Full view | 166 | Ib | Cancer/Infectious/Immunological | Betaseron | Merck | Sterile, white to off-white powder | Subcutaneous Injection | Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
| 1344 | Th1049 | Interferon beta-1a | MSYNLLGFLQRSSNFQCQKL Full view | 166 | Ib | Cancer/Infectious/Immunological | Blastoferon | Sidus | N.A. | N.A. | Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
| 1345 | Th1049 | Interferon beta-1a | MSYNLLGFLQRSSNFQCQKL Full view | 166 | Ib | Cancer/Infectious/Immunological | Extavia | Novartis | Sterile, white to off-white powder | Subcutaneous Injection | Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
| 1346 | Th1049 | Interferon beta-1a | MSYNLLGFLQRSSNFQCQKL Full view | 166 | Ib | Cancer/Infectious/Immunological | Rebif | Merck | Sterile solution in a prefilled syringe or REBIF Rebidose autoinjector | Subcutaneous Injection | Immunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors | Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
| 1379 | Th1058 | Interferon alfacon-1 | CDLPQTHSLGSRRTLMLLAQ Full view | 165 | Ib | Immunological/Infectious | INFERGEN | Kadmon Pharmaceuticals, LLC. | Sterile, clear, colorless, preservative-free liquid | Subcutaneous Injection | Antiviral Agents and Immunosuppressive Agents | Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
| 1409 | Th1067 | Daptomycin | N.A. Full view | 0 | IIa | Infectious | CUBICIN | Cubist Pharmaceuticals, Inc | Sterile, preservative-free, pale yellow to light brown, lyophilized cake containing approx 500 mg of daptomycin | Intravenous(IV) Injection | N.A. | B-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c |
| 1462 | Th1088 | Enfuvirtide | YTSLIHSLIEESQNQQEKNE Full view | 36 | IIa | Infectious | `FUZEON | Trimeris, Roche | White to off-white, sterile, lyophilized powder. | Subcutaneous injection | HIV Fusion Inhibitors | Oxytocin receptor,Oxytocin-neurophysin 1, Envelope glycoprotein |
| 1465 | Th1089 | Palivizumab | VH region: QVTLRESG< Full view | 120 | IIIa | Infectious | Synagis | MedImmune | Sterile, preservative-free liquid solution | Intramuscular injection | Antiviral Agents | N.A. |
| 1531 | Th1110 | Thymalfasin | SDAAVDTSSEITTKDLKEKK Full view | 28 | Ib | Infectious/Immunological | Zadaxin | SciClone Pharmaceuticals (SCLN) | N.A. | Subcutaneous injection | N.A. | N.A. |
| 1533 | Th1112 | Natural Alpha Interferon Or Multiferon | Inteferon alpha-1: | 997 | IIa | Cancer/Infectious | Intron/ Roferon-A | N.A. | N.A. | Subcutaneous injection, Intravenous injection, Intramuscular injection | N.A. | N.A. |
| 1536 | Th1115 | Teicoplanin | N.A. Full view | 0 | IIa | Infectious | Targocid | NPS Pharmaceuticals | Light yellow solid | Intravenous injection, Intramuscular injection | Anti-Bacterial Agents | D-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan |
| 1627 | Th1138 | Raxibacumab | N.A. Full view | 0 | IIa | Immunological/Infectious | RAXIBACUMAB | GSK | Sterile, liquid formulation in single-dose vials | N.A. | Anti-Infective Agents and Monoclonal antibodies | Protective antigen |
| 1659 | Th1152 | Drotrecogin alfa | Heavy Chain: LIDGKMT Full view | 402 | Ib | Infectious | Xigris | Eli Lilly and Company | Sterile, lyophilized, white to off-white powder | Intravenous Infusion | Antisepsis | Coagulation factor VIII, V, Plasminogen activator inhibitor 1, Thrombomodulin, Vitamin K-dependent protein S, Ceruloplasmin, Prothrombin, Platelet factor 4, Plasma serine protease inhibitor, Serpin B6, Vitamin K-dependent gamma-carboxylase, Endothelial protein C receptor |
| 1662 | Th1154 | OspA lipoprotein | MKKYLLGIGLILALIACKQN Full view | 272 | IIIa | Infectious | Lymerix | SmithKline Beecham | Sterile suspension | Intramuscular Injection | Vaccines | Toll-like receptor 2 |
| 1758 | Th1183 | Hepatitis B immune globulin | NA Full view | 0 | IIIa | Infectious Disease | Hepagam B | Cangene Bio Pharma Inc. | Injection, Solution | Intramuscular; Intravenous | NA | HBsAg |
| 1762 | Th1183 | Hepatitis B immune globulin | NA Full view | 0 | IIIa | Infectious Disease | Hyperhep B S/d | GRIFOLS USA, LLC | Injection | Intramuscular | NA | HBsAg |
| 1763 | Th1183 | Hepatitis B immune globulin | NA Full view | 0 | IIIa | Infectious Disease | Nabi-HB | Biotest Pharmaceuticals Corporation | Injection | Intramuscular | NA | HBsAg |
| 1767 | Th1185 | Human clostridium tetani toxoid immune globulin | NA Full view | 0 | IIIb | Infectious Disease | Hypertet S/d | GRIFOLS USA, LLC | Injection | Intramuscular | NA | NA |
| 1768 | Th1186 | Human rabies virus immune globulin | NA Full view | 0 | IIIa | Infectious Disease | Hyperab Rabies Immune Globulin Human | Cutter Med & Biol, Division Of Miles Canada Ltd. | Liquid | Intramuscular | NA | NA |
| 1769 | Th1186 | Human rabies virus immune globulin | NA Full view | 0 | IIIa | Infectious Disease | Hyperrab S/d | Grifols Therapeutics Inc | Solution | Intramuscular | NA | NA |
| 1770 | Th1186 | Human rabies virus immune globulin | NA Full view | 0 | IIIa | Infectious Disease | Imogam Rabies Inj 150unit/ml | Pasteur mÉrieux Serums Et Vaccins, s.a. | Clear, pale yellow to light brown liquid | Intramuscular | NA | NA |
| 1771 | Th1186 | Human rabies virus immune globulin | NA Full view | 0 | IIIa | Infectious Disease | Imogam Rabies Pasteurized | Sanofi Pasteur Limited | Solution | Intramuscular | NA | NA |
| 1798 | Th1192 | Ustekinumab | NA Full view | 0 | IIIb | Infectious Disease | Stelara | Janssen Biotech, Inc. | Solution fro Injection | Subcutaneous | Deramtologic agent, Immunosuppressive agent, antineoplastic agent | Interleukin-12 subunit beta |
| 1800 | Th1194 | Tuberculin Purified Protein Derivative | NA Full view | 0 | IV | Infectious Disease | Aplisol | Par Pharmaceutical, Inc. | Solution for Injection | Intradermal | NA | NA |
| 1814 | Th1205 | Obiltoxaximab | NA Full view | 0 | IIIa | Infectious Disease | Anthim | Elusys Therapeutics, Inc. | Liquid | Intravenous infusion | NA | NA |
| 1820 | Th1211 | Ixekizumab | NA Full view | 0 | Ic | Infectious Disease | Taltz | Eli lilly | Sterile, preservative free, clear and colorless to slightly yellow Solution | Subcutaneous | NA | NA |
| 1840 | Th1229 | Hepatitis A Vaccine | NA Full view | 0 | IIIa | Infectious Disease | Avaxim | Sanofi Pasteur Limited | Suspension | Intramuscular | Vaccine | NA |
| 1841 | Th1229 | Hepatitis A Vaccine | NA Full view | 0 | IIIa | Infectious Disease | Havrix | Dispensing Solutions, Inc. | Suspension | Intramuscular | Vaccine | NA |
| 1842 | Th1230 | Human Varicella-Zoster Immune Globulin | NA Full view | 0 | IIIa | Infectious Disease | VARIZIG | NA | lyophilized powder for solution | Intramuscular | Antibody | varicella zoster virus |